/PRNewswire/ OncoArendi Therapeutics S.A. ("OncoArendi"; WSE: OAT), a clinical stage biotechnology company that uses its world leading medicinal chemistry.
OSLO, Norway, March 11, 2022 /PRNewswire/ Reference is made to the stock exchange announcement from Nordic Nanovector ASA (the "Company") dated 19 January 2022 relating to the subsequent
OSLO, Norway, March 1, 2022 /PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces its results for the fourth quarter and full year 2021. A live webcast presentation by Nordic Nanovector's
/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces its results for the fourth quarter and full year 2021. A live webcast presentation by Nordic.
/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces its results for the fourth quarter and full year 2021. A live webcast presentation by Nordic.